Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

NAActive, not recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 17, 2026

Study Completion Date

March 17, 2026

Conditions
Lymphoma, Non-HodgkinLymphoma, Hodgkin
Interventions
OTHER

Intervention

"Evaluation of the sensitivity of the cardiac uptake of 18F-FDG measured on D28 +/- 7 days, D42 +/- 7 days ou D56 + 4 days of the administration of ATCs to identify at 1 year the patients at risk of occurrence of a LVSD defined by a drop of more than 10 units of the LVEF and LVEF \< 53%.~The patient participating in the study needs to respect a minimum of 12-hour fasting period, a high protein and a low-carbohydrate diet prior to performing PET/CT in order to limit physiological 18F-FDG myocardial fixation."

Trial Locations (1)

75012

Cardiology department, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER